A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas

Radiotherapy and temozolomide for anaplastic astrocytic gliomas

(2015) Lakshmi Nayak et al.   JOURNAL OF NEURO-ONCOLOGY

Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth

(2015) Wenchao Zhou et al.   Oncotarget

The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma

(2014) Sani H. Kizilbash et al.   JOURNAL OF NEURO-ONCOLOGY

Bevacizumab for Newly Diagnosed Glioblastoma

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Arsenic reverses glioblastoma resistance to mTOR-targeted therapies

(2013) Akio Iwanami et al.   CELL CYCLE

PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies

(2013) Akio Iwanami et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas

(2012) Sean A. Grimm et al.   JOURNAL OF NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models

(2011) Sang-Kyun Lim et al.   BMB Reports

Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting

(2010) Rihab Nasr et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells

(2010) Clement Yedjou et al.   Journal of Hematology & Oncology

Understanding the role of tumor stem cells in glioblastoma multiforme: a review article

(2010) Aalya Fatoo et al.   JOURNAL OF NEURO-ONCOLOGY

Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas

(2009) Yunbo Zhen et al.   CANCER LETTERS

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY